ResearcherWuyi UniversityActive in the last 2 years
Xuetao Xu
Matched on ORCID iD 0000-0002-6919-948X; OpenAlex author ID A5038804930. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. Co-author DOI 10.1016/j.bioorg.2023.106937↗
- Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cells. Co-author DOI 10.1016/j.ejphar.2020.173840↗
- (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells. Co-author DOI 10.1016/j.bioorg.2020.104022↗
- Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. Co-author DOI 10.7150/ijms.47546↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xi Zheng · 4 shared papers, 2020–2024 · strength 0.51
- Paper Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. DOI 10.1016/j.bioorg.2023.106937↗
- Paper Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cance… DOI 10.1016/j.ejphar.2020.173840↗
- Paper Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. DOI 10.7150/ijms.47546↗
- Dongli Li · 3 shared papers, 2020–2024 · strength 0.39
- Paper Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. DOI 10.1016/j.bioorg.2023.106937↗
- Paper Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. DOI 10.7150/ijms.47546↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022↗
- Panpan Wu · 2 shared papers, 2020–2024 · strength 0.29
- Paper Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. DOI 10.1016/j.bioorg.2023.106937↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022↗
- Xiao Wang · 2 shared papers, 2020–2021 · strength 0.22
- Paper Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cance… DOI 10.1016/j.ejphar.2020.173840↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022↗
- Kun Zhang · 2 shared papers, 2020–2021 · strength 0.22
- Paper Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cance… DOI 10.1016/j.ejphar.2020.173840↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022↗
- Wing‐Leung Wong · 1 shared paper, 2024 · strength 0.18
- Fan Zhang · 1 shared paper, 2024 · strength 0.18
- Peng Hong · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.